Suyu Liu

机构：The University of Texas MD Anderson Cancer Center, Linyi University · ORCID：0000-0003-0126-2646

发表论文 254 篇 · 总被引 5673 次 · h-index 36

代表论文

• Smartphone-Integrated Dual-Signal Imprinting Fluorescent Sensing System for Precise Recognition and Detection of Tetracycline and Oxytetracycline (2025 · ACS Applied Nano Materials · 被引 27)
• Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial (2025 · European Urology · 被引 26)
• Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer (2025 · Thyroid · 被引 10)
• Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic Significance (2025 · Modern Pathology · 被引 7)
• Randomized optimal selection design for dose optimization (2025 · Biometrics · 被引 5)
• Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial (2026 · European Journal of Cancer · 被引 1)